bluebird bio, Inc. stock price

bluebird bio, Inc. latest news:


  • 02/21/2018 14:52:22

    BRIEF-Bluebird Bio Reports Q4 Loss Per Share $2.52‍​

    Bluebird Bio Inc(BLUE): * BLUEBIRD BIO REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND HIGHLIGHTS OPERATIONAL PROGRESS. * Q4 REVENUE $4.2 MILLION VERSUS $1.6 MILLION. * ‍ENDED YEAR WITH $1.6 BILLION IN CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES​. * QTRLY LOSS PER SHARE $2.52‍​ Source text for Eikon: Further company coverage:

  • 01/09/2018 13:09:10

    CORRECTED-Bluebird to seek approvals for three treatments by end of 2019

    Jan 9 (Reuters) - U.S. biotech bluebird bio Inc, which does not yet have any marketed products, expects to be able to file for regulatory approval of three novel treatments by the end of 2019, chief executive Nick Leschly announced on Tuesday.

  • 01/09/2018 09:28:15

    BRIEF-Bluebird Bio Expects Three Regulatory Filings By End 2019

    Bluebird Bio Inc(BLUE): * BLUEBIRD BIO CEO SAYS EXPECTS THREE REGULATORY FILINGS BY END 2019. * BLUEBIRD SEES FILING FOR APPROVAL IN BETA THALASSEMIA IN 2018. * BLUEBIRD BIO SEES FILING FOR US AND EU APPROVAL OF B2121 FOR MULTIPLE MYELOMA IN 2019 Source text for Eikon: Further company coverage:

  • 12/13/2017 09:30:09

    Bluebird Bio Stumbles Over Secondary Offering


  • 12/11/2017 14:19:27

    Bluebird Bio stock retreats from records after announcing stock offering

    Bluebird Bio Inc.'s soaring stock price hit a bit of turbulence Monday afternoon, after the company said it planned to sell $600 million in fresh shares amid a run to record prices. Bluebird shares have more than tripled this year, and received a big boost in the past few sessions after presenting new research on cancer treatments last week. Shares added 17.9% Monday after a big price target boost and closed higher than $200 for the first time, but Bluebird said just after the session ended that it planned to sell $600 million in fresh shares, with the possibility of increasing the size by up to 15%. In immediate late trading after the announcement, Bluebird shares fell more than 2.5%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 12/11/2017 14:05:13

    BRIEF-Bluebird Bio Announces Proposed Public Offering Of Common Stock

    Bluebird Bio Inc(BLUE): * BLUEBIRD BIO ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK. * Bluebird Bio Inc(BLUE) - HAS COMMENCED AN UNDERWRITTEN PUBLIC OFFERING OF $600 MILLION OF ITS COMMON STOCK Source text for Eikon: Further company coverage:

  • 11/29/2017 06:31:19

    BRIEF-Bluebird Bio Acquires Manufacturing Facility In North Carolina

    Bluebird Bio Inc(BLUE): * BLUEBIRD BIO ACQUIRES MANUFACTURING FACILITY IN NORTH CAROLINA AND EXECUTES MULTIPLE GLOBAL SUPPLY AGREEMENTS TO ENHANCE ABILITY TO DELIVER GENE THERAPIES TO PATIENTS Source text for Eikon: Further company coverage:

  • More trends:

    Blueknight Energy Partners L.P., L.L.C.BKEP | Blueknight Energy Partners L.P., L.L.C.BKEPP | Blueprint Medicines CorporationBPMC | BNC BancorpBNCN | Bob Evans Farms, Inc.BOBE | BofI Holding, Inc.BOFI | Boingo Wireless, Inc.WIFI | Bojangles'', Inc.BOJA | BOK Financial CorporationBOKF | Bona Film Group LimitedBONA |